We have established a database of Human Pancreatic Cancer (HPCDb) through effectively mining, extracting, analyzing, and integrating PC-related genes, single-nucleotide polymorphisms (SNPs), and microRNAs (miRNAs), now available online at http://www.pancancer.org/. Data were extracted from established databases, ≥5 published literature (PubMed), and microarray chips (screening of differentially expressed genes using limma package in R, |log2 fold change (FC)| > 1). Further, protein-protein interactions (PPIs) were investigated through the Human Protein Reference Database. miRNA-target relationships were also identified using the online software TargetScan. Currently, HPCDb contains 3284 genes, 120 miRNAs, 589 SNPs, 10,139 PPIs, and 3904 miRNA-target pairs. The detailed information on PC-related genes (e.g., gene identifier (ID), symbol, synonyms, full name, chip sets, expression alteration, PubMed ID, and PPIs), miRNAs (e.g., accession number, 2 chromosome location, related disease, PubMed ID, and miRNA-target interactions), and SNPs (e.g., SNP ID, allele, gene, PubMed ID, chromosome location, and disease) is presented through user-friendly query interfaces or convenient links to NCBI GEO, NCBI PubMed, NCBI Gene, NCBI dbSNP, and miRBase. Overall, HPCDb provides biologists with relevant information on human PC-related molecules at multiple levels, helping to generate new hypotheses or identify candidate markers.
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focus on PC-related single-nucleotide polymorphisms (SNPs), miRNA-target relationships, and protein-protein interactions (PPIs), which are supposed to play critical roles in cancer progression (Erichsen and Chanock 2004; Zhu et al. 2013; Sun et al. 2014) .
SNPs occur every 1,000-2,000 bases (on average) in human chromosomes (Wang et al. 1998) , representing the most widespread type of sequence variation in the genome (Fareed and Afzal 2013) . Missense SNPs that fall within coding regions of genes may change the amino acid sequence of the corresponding proteins, while SNPs that fall within non-coding regions of genes may affect the sequence of non-coding RNA, transcription factor binding, mRNA degradation, or gene splicing, influencing individual responses to the environment, risk of disease, and prognosis (Sachidanandam et al. 2001) . Thus, SNPs are valuable genetic markers for disease prevention, detection, and cure. SNPs of various genes, such as NR5A2, HNF1A, DPYD, SERPINA3, and ABCG2, have been identified to be associated with PC (Petersen et al. 2010; Pierce and Ahsan 2011; Zeng et al. 2011) . Hence, SNP data are an important resource for PC research. Consisting of approximately 22 nucleotides, miRNAs have been reported to regulate protein-coding genes endogenously at the post-transcriptional level (Bartel 2004) . Evidence has indicated that miRNAs play critical roles in PC progression through regulating their target genes, and they can serve as bio-markers for PC diagnosis, targets for clinical therapies, and criteria in prognosis prediction (Giovannetti et al. 2010; Ali et al. 2011; Srivastava et al. 2011; Liu et al. 2012; Li et al. 2013 ). Hence, miRNA-target data are an important resource 5 for PC research as well. In addition, investigation of PPIs can provide novel targets for clinical therapies (Agharkar et al. 2011 ), suggesting the need to compile PPI information of PC-related genes.
In this study, to facilitate the systematic study of PC, HPCDb (Database for Pancreatic Cancer, http://www.pancancer.org/) was constructed through effective mining, extracting, analyzing, and integrating PC-related data of genes, SNPs, miRNAs, PPIs, and miRNA-target relationships.
RESULTS
HPCDb provides a search engine to survey detailed information on PC-related genes, miRNAs, and SNPs, whose identifier (ID) and/or symbol could serve as query keywords. A rough flowchart of a query is presented in Figure 1 . Upon clicking on the gene name, a new page will be displayed, where in the "chip sets" section, the word "total" demonstrates the total numbers of patients who have shown upregulation and/or downregulation of the particular gene. A further click on terms in blue will provide the link to the pages with the corresponding information in the NCBI Gene, NCBI GEO, NCBI PubMed, or HPCDb database, describing the corresponding terms in detail. A click on "PPI map view" will display a new page that illustrates the PPI network of the particular gene and the genes with which it interacts.
On the "miRNA List" page, PC-related miRNAs are also listed alphabetically.
After submission of an miRNA ID or symbol, miRNA-centered information will be displayed on a new page, including miRNA ID, accession number in miRBase, reads per million (RPM, a value demonstrating the expression level of miRNA), location (chromosome, start site, and end site), results of data mining (PubMed ID and literature count), as well as databases featuring the present miRNA, disease, source, and miRNA-target relationships. A click on miRNA ID in blue will further link to a new page in miRBase that describes the corresponding miRNA in detail, and a further click on the target genes in blue will subsequently link to new pages in HPCDb that describe the corresponding target genes in detail.
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On the "SNP List" page, PC-related SNPs are listed alphabetically as well. After submission of SNP ID, SNP-centered information will be displayed on a new page, including SNP ID, results of data mining (allele, gene, PubMed IDs), and databases featuring the present SNP (NHGRI GWAS Catalog and/or JSNP databases). A click on SNP ID in blue will further link to a new page in NCBI dbSNP that describes the corresponding SNP in detail.
On the "clinical analysis" page, three categories, namely, mRNA survival curve, miRNA survival curve, and clinical survival curve, are included. Taking mRNA as an example, there were 17,992 mRNA KM survival curves. On the one hand, after input of the gene name, the survival curve of the related genes can be searched. For example, after inputting ABCB1, the relationship between ABCB1 expression level and survival rate can be obtained, and p = 0.00099 is displayed, indicating a significant correlation between the expression level of ABCB1 and the survival time.
On the other hand, a p-value threshold can instead be input for the search. For example, a total of 2,207 results can be obtained after selecting p < 0.05. The instructions for the miRNA survival curve and clinical survival curve are the same as the instructions for the mRNA survival curve.
Discussion
PC is a cancer with extremely high incidence and mortality rate, for which no effective clinical therapy is currently available. To provide a platform for the comprehensive study of this disease, we established HPCDb, a database for Overall, as a freely available web-based resource, HPCDb provides biologists and pharmacologists with relevant information on human PC-related molecules at multiple levels, helping to generate new hypotheses or identify candidate markers.
MATERIALS AND METHODS

Database construction
Relevant data were extracted from established databases, published literature, and microarray chips. The collected data were then analyzed, integrated, and annotated, as shown in Figure 2 . 
PC-related genes
To collect PC-related genes, the following searches were performed: (1) known genes were extracted from PC-GDB, PED, and Ensembl (http://www.ensembl.org), which store comparative genomics, variation, and regulatory data (Flicek et al. 2012 file 4) . All of the supplemented annotations of selected genes were used for database construction.
PC-related miRNAs
For PC-related miRNAs, the following procedures were performed: (1) 
PC-related SNPs
For PC-related SNPs, we utilized the following search methods: (1) 
PC-related clinical analysis
For PC-related clinical analysis, the RNA-seq and miRNA-seq level 3 data of PC in the TCGA database (https://cancergenome.nih.gov/) and PC clinical data were downloaded. Survival curve analysis for PC was performed according to the expression level of mRNAs and miRNAs as well as demographic and clinical characteristics (age, sex, and grade). Survival analysis was conducted for 17,992 mRNAs and 457 miNRAs, and 2207 mRNAs and 29 miRNAs were found to affect the survival time of PC significantly (p < 0.05). Survival analysis for age, sex, and grade found that these three clinical indices did not significantly affect the survival time of PC.
